Disease reprogression following surgical resection in Crohn disease
Inflammatory Bowel Diseases · 2026
DOI: 10.1093/ibd/izag035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, 2026. Verfasst von Sara Ghoneim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, United States. Hauptthemen laut MEDLINE: Crohn Disease, Postoperative Complications. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, The Leona M. and Harry B. Helmsley Charitable Trust, National Institutes of Health.
Abstract (Originalsprache)
Background
Ileocecal resection (ICR) for stricturing (B2) or internal penetrating (B3) phenotypes of Crohn disease (CD) is associated with higher rate of recurrence. Whether patients are at an increased risk of reprogression to complicated behavior (B2/B3) after index surgery remains unknown.
Methods
This retrospective study included adult patients with CD who underwent ICR during 1990-2020. We extracted disease characteristics, preoperative and postoperative treatments. The primary outcome was reprogression to B2/B3 disease following ICR. Multivariable logistic regression was used to assess the association between preoperative phenotype and postoperative disease behavior, adjusting for confounders.
Results
Our study included 297 patients with CD who underwent ICR between 1990-2020. Over half (52%) were male, the mean age at surgery was 36 years, and the mean disease duration was 15 years. At resection, disease phenotypes were B1 (nonstricturing, nonpenetrating) in 20%, B2 in 54%, and B3 in 25%. Postoperatively, 56% of patients received advanced therapy. After a median follow-up period of 14 years, 73% of patients had B1, 23% developed B2, and 4% developed B3 disease. Disease reprogression to B2/B3 disease was independent of preoperative disease behavior (P = .90) with 68%, 74%, and 75% of patients whose disease was B1, B2, or B3 at surgery, respectively, having their disease reclassified as B1 at last follow-up. Only 3% of those who underwent surgery for B3 redeveloped B3 disease.
Conclusions
Recurrence of stricturing or penetrating complications following an initial ileocecal resection is independent of preoperative phenotype in CD under contemporary CD management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Gastroenterology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, United States.
- Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, United States.
- Division of Pediatric Gastroenterology, Massachusetts General Hospital, Boston, MA 02114, United States.
ORCID-Profile: Sara Ghoneim, Ashwin N Ananthakrishnan
Förderung
- NIH HHS
- The Leona M. and Harry B. Helmsley Charitable Trust
- National Institutes of Health
Zitieren
APA
Ghoneim, S., Dicken, Q., Omede, M., Harris, H., Law, C. C. Y., & Ananthakrishnan, A. N. (2026). Disease reprogression following surgical resection in Crohn disease. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izag035
Vancouver
Ghoneim S, Dicken Q, Omede M, Harris H, Law CCY, Ananthakrishnan AN. Disease reprogression following surgical resection in Crohn disease. Inflammatory Bowel Diseases. 2026. doi:10.1093/ibd/izag035
BibTeX
@article{Ghoneim2026,
author = {Ghoneim, Sara and Dicken, Quinten and Omede, Mmeyeneabasi and Harris, Hailey and Law, Cindy C Y and Ananthakrishnan, Ashwin N},
title = {Disease reprogression following surgical resection in Crohn disease},
journal = {Inflammatory Bowel Diseases},
year = {2026},
doi = {10.1093/ibd/izag035}
}
EUVIMED